Plain-English translation of NCT05476913 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After a stroke, people who cannot move around are at risk of developing dangerous blood clots in their legs. This trial compares two ways to prevent those clots: the geko™ device, a wearable treatment that uses gentle electrical stimulation to improve blood flow in the legs, and intermittent pneumatic compression (IPC), the standard treatment that uses air-filled cuffs to squeeze the legs. The study will show which treatment works better.
Not all stroke patients can tolerate or use the standard IPC treatment safely, so researchers want to see if the geko device could be a better option for preventing blood clots in immobile stroke patients.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the geko device or the standard IPC treatment, which will be applied to both legs and worn continuously. Your treatment will last up to 30 days or until you can walk without help, whichever comes first. During this time, you'll have leg ultrasound scans at 7 and 14 days, answer questions about comfort, and have phone follow-ups at 30 and 90 days to check on your recovery and quality of life.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
United Kingdom